"Trump represents an unprecedented threat to America," Altman wrote in 2016. The day after President Donald Trump returned to office, SamAltman, the CEO of tech giant OpenAI, stood behind the ...
Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...